Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 7/20 | 0.49 |
| ▸ | COMT | P21964 | 5/20 | 0.49 |
| ▸ | TTR | P02766 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | JUN | P05412 | 1/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.34 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.34 |
| ▸ | SNCA | P37840 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32670154 | 0.94 | FTO (0.49) | FTOCOMTTTREGFRMAOA | |
| SCHEMBL32669640 | 0.92 | FTO (0.50) | FTOCOMTTTREGFRJUN | |
| SCHEMBL32670125 | 0.91 | FTO (0.49) | FTOCOMTTTREGFRABCB1 | |
| SCHEMBL32669803 | 0.91 | FTO (0.49) | FTOCOMTTTREGFR | |
| SCHEMBL32670003 | 0.91 | FTO (0.51) | FTOCOMTTTREGFRMAOA | |
| SCHEMBL32669713 | 0.91 | FTO (0.60) | FTOCOMTTTRMAOAMAOB | |
| SCHEMBL32669939 | 0.90 | FTO (0.49) | FTOCOMTTTREGFR | |
| SCHEMBL32670023 | 0.89 | FTO (0.50) | FTOCOMTTTREGFRJUN | |
| SCHEMBL32669992 | 0.89 | FTO (0.51) | FTOCOMTTTREGFRABCB1 | |
| SCHEMBL32669642 | 0.89 | FTO (0.52) | FTOCOMTTTREGFRJUN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035341-A1 | FTO INHIBITORS | RPXDS CO LTD (CN) | 2026-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035341-A1 | FTO INHIBITORS | FTO, LDLR, GPR119 | FTO 1/4885COMT 52/4885TTR 655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.